---
figid: PMC3765447__1897-4287-11-9-3
figlink: /pmc/articles/PMC3765447/figure/F3/
number: F3
caption: Schematic representation of signaling pathways involving EPCAM, proposed
  by Maetzel D et al. (2009)[]. (a) Cleavage of EPCAM by TACE and PS-2. (b)EPCAM signalling
  and possible cross-talk with E-cadherin and Wnt pathways. EPCAM signalling is induced
  by RIP, leading to EpICD nuclear translocation in a complex with FHL2 and -catenin.
  Within the nucleus, the EpICD complex interacts with Lef-1 and contacts DNA. Upon
  interference with E-cadherin, EPCAM may increase the availability of its interaction
  partner -catenin in the soluble fraction. Cross-talk with the Wnt pathway is conceivable
  at the level of -catenin and Lef-1 interactions with EpICD, and is known for induction
  of the EPCAM promoter by Tcf4 (Maetzel D, Denzel S, Mack B, et al., Nature Cell
  Biology 11, 162 – 171, 2009).
pmcid: PMC3765447
papertitle: Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature
  review.
reftext: Katarzyna Tutlewska, et al. Hered Cancer Clin Pract. 2013;11(1):9-9.
pmc_ranked_result_index: '17734'
pathway_score: 0.9273531
filename: 1897-4287-11-9-3.jpg
figtitle: Signaling pathways involving EPCAM, proposed by Maetzel D et al
year: '2013'
organisms:
- Homo sapiens
ndex: c29684dd-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3765447__1897-4287-11-9-3.html
  '@type': Dataset
  description: Schematic representation of signaling pathways involving EPCAM, proposed
    by Maetzel D et al. (2009)[]. (a) Cleavage of EPCAM by TACE and PS-2. (b)EPCAM
    signalling and possible cross-talk with E-cadherin and Wnt pathways. EPCAM signalling
    is induced by RIP, leading to EpICD nuclear translocation in a complex with FHL2
    and -catenin. Within the nucleus, the EpICD complex interacts with Lef-1 and contacts
    DNA. Upon interference with E-cadherin, EPCAM may increase the availability of
    its interaction partner -catenin in the soluble fraction. Cross-talk with the
    Wnt pathway is conceivable at the level of -catenin and Lef-1 interactions with
    EpICD, and is known for induction of the EPCAM promoter by Tcf4 (Maetzel D, Denzel
    S, Mack B, et al., Nature Cell Biology 11, 162 – 171, 2009).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT9A
  - MYC
  - EPCAM
  - CDH1
  - WNT8B
  - FHL2
  - WNT10B
  - GSK3B
  - WNT8A
  - WNT7B
  - WNT2
  - AXIN2
  - CTNNB1
  - WNT3A
  - WNT5B
  - WNT3
  - WNT9B
  - WNT7A
  - AXIN1
  - WNT11
  - WNT5A
  - WNT10A
  - WNT1
  - ADAM17
  - WNT6
  - WNT2B
  - WNT16
  - APC
  - WNT4
  - Cancer
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: c-myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: EPCAM
  symbol: EPCAM
  source: hgnc_symbol
  hgnc_symbol: EPCAM
  entrez: '4072'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: FHL2
  symbol: FHL2
  source: hgnc_symbol
  hgnc_symbol: FHL2
  entrez: '2274'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: GSK3-B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: TACE
  symbol: TACE
  source: hgnc_prev_symbol
  hgnc_symbol: ADAM17
  entrez: '6868'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3765447__F3
redirect_from: /figures/PMC3765447__F3
figtype: Figure
---
